Gero

we are a preclinical stage ai drug discovery company with a mission to eliminate age-related diseases we use ai to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. then wes-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once. you can find our publications here: https://gero.ai/publications